Pioneers novel TCR-targeting antibodies to selectively activate T cell subsets for rapid, effective, and durable cancer immunotherapy.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Marengo Therapeutics is a clinical-stage biotech company pioneering a new way to activate the body’s immune system to mount rapid, effective, and durable responses against cancer. The company develops novel TCR-targeting antibodies that selectively modulate specific T cell subsets to combat cancer and other diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Marengo Therapeutics Management Team
Investors
Apple Tree Partners
Marengo Therapeutics Valuations & Financials
View real-time NPM data on Marengo Therapeutics stock including daily Marengo Therapeutics stock price estimates, valuation history, and historical share price information. Access Marengo Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Marengo Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Marengo Therapeutics? Get in touch to learn more.
Similar Companies
like Marengo Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Particella
Healthcare & Life Sciences
Creates technology that delivers nucleic acid medicines orally for targeted treatment in the gastrointestinal tract.
Guidesly
Commerce & Marketplaces
Online marketplace connecting outdoor enthusiasts with recreational guides for fishing, hunting, and water sports through customer experience tools.
VenoStent
Healthcare & Life Sciences
Develops bioresorbable polymer wraps to prevent vascular access surgery failures in hemodialysis patients, addressing a critical healthcare challenge.
New Frontier Aerospace
Industrials
Developer of advanced propulsion technologies for aircraft and spacecraft, revolutionizing global air and space transportation.
FAQ
We have answers
Marengo Therapeutics stock does not trade on public stock exchanges. Marengo Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Marengo Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Marengo Therapeutics Stock does not trade on public stock exchanges. In order to sell Marengo Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Marengo Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Marengo Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Marengo Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Marengo Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Marengo Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Marengo Therapeutics is a private company and has not had an IPO. There is currently no Marengo Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Marengo Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
